SPY is an exchange-traded fund (ETF) that aims to replicate the performance of the S&P 500 Index. The S&P 500 Index includes 500 of the largest publicly traded companies in the United States, representing a broad cross-section of the U.S. economy.
Metrics and analysis →BIB
BIB, or ProShares Ultra Biotech, is an exchange-traded fund (ETF) designed to provide twice the daily return of the S&P Biotechnology Select Industry Index. It is a leveraged ETF, aiming to deliver 2x the daily performance of the underlying index.
- Open
- 53.10
- High
- 54.00
- Low
- 51.00
- Prev close
- 53.10
- Volume
- 41K
- Avg vol 10
- 10K
Today · Market closed · opens Mon 9:30 AM
BIB chart
Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history
Technical analysis
Daily bars · last bar Nov 20, 2026 · close 51.00
Leaning sell. 10 of 18 signals point down against 4 up, carried by momentum, trend and volume. Volatility leans buy. RSI, Stochastic, Stoch RSI, Williams %R and CCI sit in oversold territory.
Trend
Momentum
Volatility
Volume
Strong sell. The close is above 0 of 24 averages and below 24. Short- and long-term averages agree: price is below both. SMA 50 is above SMA 200 (110.86 vs 96.69).
| Period | SMA | EMA | WMA | WEMA |
|---|---|---|---|---|
| 5 | 86.73 | 78.68 | 74.90 | 91.89 |
| 10 | 103.66 | 93.92 | 92.36 | 103.26 |
| 20 | 110.70 | 103.78 | 104.54 | 108.25 |
| 50 | 110.86 | 108.79 | 109.56 | 106.55 |
| 100 | 109.63 | 106.45 | 110.81 | 98.54 |
| 200 | 96.69 | 97.79 | 103.57 | 88.52 |
Green: the close is above that average. Red: below it.
From the bar before the last one. Nearest classic support is S3 at 50.07. Nearest resistance is S2 at 51.89.
| Level | Classic | Fibonacci | Camarilla | Floor | Woodie | DeMark |
|---|---|---|---|---|---|---|
| R3 | 57.35 | 55.53 | 53.60 | 56.13 | 55.83 | — |
| R2 | 55.53 | 54.83 | 53.43 | 55.53 | 55.38 | — |
| R1 | 54.31 | 54.40 | 53.27 | 54.31 | 54.01 | 54.01 |
| Pivot | 53.71 | 53.71 | 53.71 | 53.71 | 53.56 | 53.56 |
| S1 | 52.49 | 53.01 | 52.93 | 52.49 | 52.19 | 52.19 |
| S2 | 51.89 | 52.58 | 52.77 | 51.89 | 51.74 | — |
| S3 | 50.07 | 51.89 | 52.60 | 50.67 | 50.37 | — |
Patterns that formed on the last 5 bars, newest first.
A long candle with no shadow at the close: it closed at its high (bullish) or its low (bearish).
Sellers held control into the close.
A candle with a short body and short shadows: a quiet bar.
A small loss on little range; weak on its own.
An inside bar, then a break out of it one way that fails and reverses.
A false break lower trapped sellers; price may run up.
A doji with long shadows both ways.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
A small body at the top of the candle with a lower shadow at least twice as long, after a decline.
Sellers drove price down and lost it by the close; a turn up may follow, best confirmed by the next candle.
A candle with a short body and short shadows: a quiet bar.
A small loss on little range; weak on its own.
How candlestick references usually rate the pattern. It is not a success rate measured on this ticker. About candle patterns
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| Nov 20, 2026 | 53.10 | 54.00 | 51.00 | 51.00 | 42K | −2.10 |
| Nov 19, 2026 | 54.91 | 54.92 | 53.10 | 53.10 | 22K | −1.81 |
| Nov 18, 2026 | 108.84 | 110.14 | 108.38 | 108.38 | 2K | −0.46 |
| Nov 17, 2026 | 110.63 | 110.63 | 108.00 | 109.85 | 5K | −0.78 |
| Nov 16, 2026 | 114.50 | 115.16 | 111.04 | 111.32 | 4K | −3.18 |
| Nov 13, 2026 | 115.88 | 116.60 | 114.30 | 116.13 | 5K | +0.25 |
| Nov 12, 2026 | 120.02 | 120.53 | 117.41 | 117.41 | 6K | −2.61 |
| Nov 11, 2026 | 122.35 | 123.45 | 121.13 | 123.13 | 4K | +0.78 |
| Nov 10, 2026 | 122.39 | 122.93 | 120.00 | 122.13 | 5K | −0.26 |
| Nov 9, 2026 | 120.00 | 125.00 | 118.00 | 124.13 | 8K | +4.13 |
| Nov 6, 2026 | 112.00 | 118.03 | 112.00 | 117.73 | 6K | +5.73 |
| Nov 5, 2026 | 124.12 | 124.12 | 112.46 | 112.66 | 36K | −11.46 |
| Nov 4, 2026 | 123.08 | 125.39 | 118.12 | 125.11 | 8K | +2.03 |
| Nov 3, 2026 | 117.73 | 120.43 | 117.73 | 118.78 | 6K | +1.05 |
| Nov 2, 2026 | 121.42 | 121.46 | 117.08 | 117.10 | 8K | −4.32 |
| Oct 30, 2026 | 122.20 | 125.27 | 119.61 | 120.53 | 28K | −1.67 |
| Oct 29, 2026 | 121.35 | 123.23 | 118.81 | 120.53 | 7K | −0.82 |
| Oct 28, 2026 | 116.65 | 118.83 | 116.65 | 118.56 | 5K | +1.91 |
| Oct 27, 2026 | 110.15 | 115.38 | 110.15 | 115.27 | 5K | +5.12 |
| Oct 26, 2026 | 111.32 | 111.32 | 110.72 | 111.07 | 3K | −0.25 |
| Oct 23, 2026 | 111.15 | 111.15 | 108.41 | 110.32 | 4K | −0.83 |
| Oct 22, 2026 | 116.43 | 116.43 | 109.76 | 112.85 | 8K | −3.58 |
| Oct 21, 2026 | 114.94 | 115.64 | 113.94 | 114.71 | 27K | −0.23 |
| Oct 20, 2026 | 112.20 | 114.02 | 112.20 | 113.95 | 5K | +1.75 |
| Oct 19, 2026 | 108.50 | 109.00 | 106.48 | 107.09 | 2K | −1.41 |
| Oct 16, 2026 | 111.09 | 111.22 | 104.83 | 105.10 | 8K | −5.99 |
| Oct 15, 2026 | 110.78 | 112.32 | 110.78 | 111.11 | 8K | +0.33 |
| Oct 14, 2026 | 104.00 | 107.41 | 103.09 | 106.82 | 5K | +2.82 |
| Oct 13, 2026 | 105.05 | 106.57 | 103.59 | 103.59 | 6K | −1.46 |
| Oct 12, 2026 | 110.62 | 110.90 | 108.40 | 108.79 | 3K | −1.83 |
Performance
Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures
1 month return
-54.67%
Change in value over the past month.
3 month return
-57.69%
Change in value over the last three months.
Max drawdown
59.47%
Largest fall from a peak to the low that followed.
Standard deviation
72.52%
How far daily returns stray from their average, annualised.
Sharpe ratio
-0.21
Return above the risk-free rate per unit of volatility.
Calmar ratio
-0.26
Annualised return against the maximum drawdown.
BIB summary
Loading summary…
BIB, answered
What is the expense ratio of BIB?
BIB has an expense ratio of approximately 0.95%. This fee represents the cost of managing the fund, including administrative and operational expenses, and is expressed as a percentage of the fund’s average net assets.
Can BIB be used in a retirement account?
Yes, BIB can be held in retirement accounts such as IRAs or 401(k)s. However, due to its leveraged nature and higher risk profile, it’s important to consider how it fits within your overall investment strategy and risk tolerance.
What are the risks associated with investing in BIB?
Risks include high volatility and the potential for substantial losses due to the leveraged nature of the ETF. BIB’s performance is highly sensitive to daily changes in the biotech sector, and its use of leverage can amplify both gains and losses.
How is BIB managed?
BIB is managed by ProShares and seeks to achieve its investment objective by using financial instruments, including derivatives such as futures contracts, options, and swap agreements. It aims to provide leveraged exposure to the biotechnology sector.
What are the key performance metrics for BIB?
Key performance metrics for BIB include its net asset value (NAV), expense ratio, daily return performance, and leverage ratio. BIB's performance is designed to be twice that of the S&P Biotechnology Select Industry Index on a daily basis.
How often does BIB distribute dividends?
BIB typically distributes dividends on a quarterly basis. These dividends are generated from income produced by the underlying securities in the ETF, though leveraged ETFs may have lower yield compared to non-leveraged funds.
What is the historical performance of BIB?
Historical performance data for BIB includes past returns, NAV, and volatility. Investors should review performance charts and reports to understand how BIB has tracked its leveraged objective over different time periods.
How can I invest in BIB?
Investors can purchase shares of BIB through a brokerage account. It is traded on major stock exchanges under the ticker symbol "BIB" and can be bought and sold like other stocks and ETFs.
How does BIB handle index rebalancing or changes?
BIB rebalances its holdings daily to maintain its leverage ratio of 2x the daily performance of the S&P Biotechnology Select Industry Index. This daily rebalancing can lead to differences in performance over time compared to the index due to the effects of compounding.
What are some similar ETFs to BIB?
Similar ETFs to BIB include: LABU (Direxion Daily S&P Biotech Bull 3X Shares), which seeks to provide three times the daily performance of the S&P Biotechnology Select Industry Index; IBB (iShares Nasdaq Biotechnology ETF), which tracks the Nasdaq Biotechnology Index and provides exposure to biotechnology and pharmaceutical companies; and XBI (SPDR S&P Biotech ETF), which tracks the S&P Biotechnology Select Industry Index and provides broad exposure to the biotech sector.
Top market assets
Discover our curated selection of top-performing exchange-traded funds (ETFs) that represent a diverse range of investment opportunities.
QQQ is an exchange-traded fund (ETF) that tracks the performance of the Nasdaq-100 Index. This index includes 100 of the largest non-financial companies listed on the Nasdaq Stock Market, primarily focusing on technology and innovation sectors.
Metrics and analysis →DIA is an exchange-traded fund (ETF) that aims to track the performance of the Dow Jones Industrial Average (DJIA). The DJIA is a stock market index consisting of 30 large, publicly traded companies in the United States, representing a broad range of industries.
Metrics and analysis →IWM is an exchange-traded fund (ETF) that seeks to track the performance of the Russell 2000 Index. The Russell 2000 Index measures the performance of the 2,000 smallest stocks in the Russell 3000 Index, representing a broad segment of small-cap U.S. companies.
Metrics and analysis →Unlock Your BIB Trading Now
Achieve superior trading results with OHLCX Markets. Our platform provides expert analysis and actionable insights for BIB, utilizing the latest technology to refine your investment approach. Transform your trading strategy now now and see the impact on your trading success!
Disclaimers
The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.
With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.
Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.
Securities products are: Not FDIC insured · Not bank guaranteed · May lose value
Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.